ABGX Abgenix (MM)

FREMONT, Calif., Oct. 18 /PRNewswire-FirstCall/ -- Abgenix, Inc. (NASDAQ:ABGX) will announce third quarter financial results on Tuesday, October 25, 2005, after the close of financial markets. Following the announcement, Abgenix will host a conference call at 1:30 p.m. Pacific Time to review the company's financial results and product developments. The live and archived webcasts of the conference call will be available on the Abgenix website, http://www.abgenix.com/. To participate in the conference call, please dial 866-700-7441 or 617-213-8839 fifteen minutes before start time. The pass code for the live call is 74073994. A telephonic replay of the call will be available through November 8, 2005 by dialing 888-286-8010 or 617-801-6888. The replay participant code is 87765844. About Abgenix Abgenix is a biopharmaceutical company focused on the discovery, development and manufacturing of fully human therapeutic antibodies. The company's antibody development platform includes a leading antibody technology and state-of-the-art manufacturing capabilities that enable the rapid generation, selection and production of high affinity antibodies with the potential to target disease. Abgenix leverages its leadership position in human antibody technology to build a diversified product portfolio through its own development efforts and the establishment of collaborations with multiple pharmaceutical and biotechnology companies. For more information on Abgenix, visit the company's website at http://www.abgenix.com/. DATASOURCE: Abgenix, Inc. CONTACT: Greg Mann, Director, Corporate Communications & Investor Relations, of Abgenix, Inc., +1-510-284-6566 Web site: http://www.abgenix.com/

Copyright